Zenapax Interactions
There are 477 drugs known to interact with Zenapax (daclizumab), along with 5 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 50 are major, 418 are moderate, and 9 are minor.
- View all 477 medications that may interact with Zenapax
- View Zenapax alcohol/food interactions (1)
- View Zenapax disease interactions (5)
Most frequently checked interactions
View interaction reports for Zenapax (daclizumab) and the medicines listed below.
- Actemra (tocilizumab)
- Adcirca (tadalafil)
- Aptivus (tipranavir)
- Arixtra (fondaparinux)
- Azactam (aztreonam)
- Banzel (rufinamide)
- Baraclude (entecavir)
- Biaxin XL (clarithromycin)
- Buphenyl (sodium phenylbutyrate)
- CellCept (mycophenolate mofetil)
- Clozaril (clozapine)
- Complera (emtricitabine / rilpivirine / tenofovir disoproxil)
- Cosentyx (secukinumab)
- Crysvita (burosumab)
- Doxil (doxorubicin liposomal)
- Emergen-C (multivitamin with minerals)
- Erythrocin (erythromycin)
- Evotaz (atazanavir / cobicistat)
- Firazyr (icatibant)
- Humira (adalimumab)
- Iclusig (ponatinib)
- Idelvion (coagulation factor ix)
- Ilumya (tildrakizumab)
- Imbruvica (ibrutinib)
- Incivek (telaprevir)
- indapamide
- Integrilin (eptifibatide)
- Intelence (etravirine)
- Isentress (raltegravir)
- isoniazid
Zenapax alcohol/food interactions
There is 1 alcohol/food interaction with Zenapax (daclizumab).
Zenapax disease interactions
There are 5 disease interactions with Zenapax (daclizumab) which include:
Report options
QR code containing a link to this page
More about Zenapax (daclizumab)
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: interleukin inhibitors
- Breastfeeding
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.